ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,481Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 2094

$1.19M Total Retail Price of All Prescriptions

Rank: 55 out of 2094

503 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

44% of this provider’s 503 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 503 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 8,733 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OXYCODONE HCL 701 226 S2 1 63
NIASPAN 575 312 10 2 145
ENALAPRIL MALEATE 488 290 3 25
ZOLPIDEM TARTRATE 460 246 4 14
PRAVASTATIN SODIUM 456 242 5 18
SIMVASTATIN 451 278 6 1
ENDOCET 418 155 S2 7 88
METFORMIN HCL 370 207 8 8
PROAIR HFA 326 132 9 45
OMEPRAZOLE 309 184 10 4
ADVAIR DISKUS 290 99 11 36
AMLODIPINE BESYLATE 265 161 12 2
MELOXICAM 255 161 13 49
POTASSIUM CHLORIDE 253 148 14 24
CRESTOR 224 136 15 15
FUROSEMIDE 202 160 16 6
LEVOTHYROXINE SODIUM 197 109 17 3
CARVEDILOL 186 108 18 19
AZITHROMYCIN 182 90 19 27
NEXIUM 178 73 20 16
FLUTICASONE PROPIONATE 178 80 20 41
METOPROLOL TARTRATE 174 85 22 10
GABAPENTIN 172 94 23 23
GLYBURIDE-METFORMIN HCL 172 125 R 23 94
SINGULAIR 170 59 25 64
ATORVASTATIN CALCIUM 158 98 26 5
GLIMEPIRIDE 156 112 27 31
TRICOR 151 90 28 99
JANUVIA 151 96 28 35
SERTRALINE HCL 147 82 30 26
CHLORTHALIDONE 145 76 31 200
TAMSULOSIN HCL 141 84 32 29
SPIRIVA 138 53 33 60
METOPROLOL SUCCINATE 135 84 34 9
LOVAZA 130 63 35 53
TOPIRAMATE 130 17 35 199
AMLODIPINE BESYLATE-BENAZEPRIL 111 97 37 58
OXYCONTIN 105 11 S2 38 98
LYRICA 104 45 39 85
ALENDRONATE SODIUM 103 73 40 30
DIOVAN 103 68 40 13
WELCHOL 102 60 42 146
CLOPIDOGREL 101 62 43 22
LISINOPRIL 97 52 44 7
SPIRONOLACTONE 92 64 45 93
HYDROCORTISONE VALERATE 91 39 46 268
PATANOL 85 56 47 198
FENOFIBRATE 84 36 48 104
DONEPEZIL HCL 83 70 49 20
CLONIDINE HCL 82 16 50 62
KLOR-CON M20 81 51 51 106
RISPERIDONE 81 58 51 56
CYCLOBENZAPRINE HCL 80 21 R 53 115
COMBIVENT 77 33 54 211
ZETIA 77 60 54 79
NAMENDA 77 45 54 32
PLAVIX 73 41 57 38
LOSARTAN POTASSIUM 73 59 57 17
FENTANYL 73 12 S2 57 68
VENTOLIN HFA 73 24 57 132
DIOVAN HCT 71 54 61 28
CIPROFLOXACIN HCL 70 38 62 81
CHOLESTYRAMINE 67 48 63 463
BYSTOLIC 67 32 63 83
INSULIN SYRINGE 65 35 65 143
LIDODERM 65 35 65 59
MONTELUKAST SODIUM 64 22 67 128
LANTUS 64 40 67 66
CYMBALTA 64 12 67 61
TRAZODONE HCL 63 21 70 72
LIPITOR 62 39 71 39
DIGOXIN 60 34 72 51
OXYCODONE-ACETAMINOPHEN 60 36 S2 72 40
TRAMADOL HCL 59 49 74 33
GLIPIZIDE 57 39 75 82
LANSOPRAZOLE 57 13 75 144
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 77 52
VESICARE 56 25 77 152
FAMOTIDINE 56 42 77 34
AMMONIUM LACTATE 55 26 80 185
JANUMET 55 29 80 86
LEVOCETIRIZINE DIHYDROCHLORIDE 55 16 80 169
KRISTALOSE 54 40 83 509
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 22 83 55
LANTUS SOLOSTAR 53 33 85 76
CLOTRIMAZOLE-BETAMETHASONE 53 15 85 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.